Search Results

The San Francisco Business Times has named Gladstone Institutes President Deepak Srivastava, MD, as one of the Most Admired CEOs among Bay Area businesses and nonprofits.

Gladstone Institutes and the Chan Zuckerberg Biohub signed an affiliation agreement to increase their research collaboration.

Gladstone Institutes has partnered with the Parker Institute for Cancer Immunotherapy, the leading network of immuno-oncology expertise in the world, to establish a new research center focused on using genomics and CRISPR technology to program the human immune system to treat cancer.

InvisiShield Technologies Ltd. today announced a collaboration with Gladstone Institutes to develop intranasal preventatives against airborne infection, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV).

GenScript USA Inc. is collaborating with researchers at the Gladstone-UCSF Institute of Genomic Immunology to advance the development of new, non-viral cell therapies that modify genomic sequences in the pursuit of more effective cell therapy products while limiting the cellular toxicity that is typically associated with previously available methods.